3T Biosciences Competitors and Similar CompaniesClear all
3T Biosciences's competitors and similar companies include Alpha Tau Medical, Eutilex, Zymeworks and Foghorn Therapeutics.
 Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. |  Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | ||
Founding Date | Founding Date 2017 | Founding Date 2016 | Founding Date 2015 | Founding Date 2003 | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Tel Aviv-Yafo, IL HQ Boston, US | Locations KR HQ | Locations Vancouver, CA HQ Seattle, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 306% decrease | Employees 1041% increase | Employees 141 | Employees 45519% increase | Employees 1123% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 973.3 m | Valuation ($) 452 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₩9.5b (FY, 2024) | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income (₩29.5b) (FY, 2024) | Net income ($81.1m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 12m (over 8 years ago) | Latest funding round $ 26m (about 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 12m | Total funding raised $ 55m | Total funding raised $ 18.9m | Total funding raised $ 125.9m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Alpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
104↑ 1% increase
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
View companyEutilex
HQ
KR
Employees
141
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company